$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
FDA批准首个急性髓性白血病(AML)靶向新药米哚妥林!
2025-10-19 11:44:20
Check Details
普纳替尼进医保了吗?普纳替尼疗效怎么样?
2025-10-19 11:44:20
Check Details
格列卫的用法用量是怎样的?治疗期间的禁忌和注意事项是什么?
2025-10-19 11:44:20
Check Details
格列卫可以用医保购买吗?格列卫有什么副作用?
2025-10-19 11:44:20
Check Details
美国FDA批准艾伏尼布ivosidenib用于治疗急性髓系白血病
2025-10-19 11:44:20
Check Details
急性T-淋巴细胞白血病患者全新选择——奈拉滨(Nelarabine)
2025-10-19 11:44:20
Check Details
淋巴细胞性白血病药-奈拉滨(Atriance)
2025-10-19 11:44:20
Check Details
奈拉滨治疗急性T淋巴细胞白血病取得较好的疗效
2025-10-19 11:44:20
Check Details
白血病新药吉瑞替尼在中国获批!可显著提高生存率
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病怎么服用?需要注意什么事项?
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病疗效如何?达沙替尼副作用是什么?
2025-10-19 11:44:20
Check Details
T细胞恶性肿瘤克星——奈拉滨Atriance(诺华德国版)
2025-10-19 11:44:20
Check Details
1
2
...
643
644
645
646
647
648
649
...
933
934
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
2
Kresladi Approved by FDA: First Gene Therapy for Severe LAD-I
3
Pegcetacoplan Side Effects and Medication Safety Complete Guide
4
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
5
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
6
Is MDS Targeted Therapy Chemotherapy? Mechanism, Genetic Testing, and Personalized Care Guide
7
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
8
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
9
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
10
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor
11
Does Ixazomib (Ninlaro) Require Long-Term Use to Be Effective?
12
What is the effectiveness of the new weapon for myeloma patients: cetuximab? Listen to what the user has to say